Precision Medicine

in FSGS and Minimal Change Disease

Registry Hosting

Nephrology Research

Analytics to support research questions

FSGS

Clinical Trials

Researchers have found that in some patients when two markers in the urine are at higher levels, this can indicate that a protein called TNF is an component in causing FSGS and Minimal Change Disease to be active.

 

In this study, we are looking to see if a medication called Humira will block the TNF pathway, causing the levels of the two urine markers to decrease.

Who may be eligible?

  • Willing to give urine sample to evaluate TNF activation for screening

  • FSGS or Minimal Change Disease on biopsy

  • 6-70 years of age

  • GFR > 45 ml/min

  • Urine protein ≥1.5 g/g creatinine at screening

For more information:

Click here

Call KRN at (734) 232-4830 or toll free (844) 618-2478

Email at KidneyResearchNet@med.umich.edu 

Kidney Research Network   2020

 

Contact Us